ABAsa A. Brockman

Asa A. Brockman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asa A. Brockman has a total of 99 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells

    by Stephanie Solis, Asa A. Brockman, Claire E. Cross, Madeline J. Grider-Hayes, Christopher S. Jetter, Nicholas M. Negretti, Bret C. Mobley, Akshitkumar Mistry, Silky Chotai, Kyle D. Weaver, et al.

    Adult glioblastoma (GBM) is an aggressive brain tumor that has yet to benefit from advances in immunotherapy. Prior studies report contrasting leukocyte immunophenotypes between tumors and an association between myeloid macrophage infiltration and worse patient outcomes. IL-8, a cytokine with both inflammatory and suppressive roles, was recently associated with M2 macrophage phenotypes in GBM. These observations raise key questions: do GBM macrophages suppress or support other immune cells, is IL-8 in GBM a mechanistic driver of GBM macrophage function, and can IL-8 instruct macrophages in situ within tumors? Here, functional experiments with primary human GBM tumor cells from initial surgical resections showed that IL-8 from GBM contributes to and is sufficient to instruct monocyte-derived macrophages that suppress healthy T cells. Notably, IL-8 protein expression was enriched in aggressive tumors contacting the V-SVZ region and was not associated with increased infiltration of cells expressing the IL-8 receptors CXCR1/CXCR2. Suppressor cells instructed by GBM ex vivo phenotypically matched myeloid macrophages observed in vivo, and neutralizing IL-8 during instruction blocked this and restored T cell proliferation. Analysis of IL-8 RNA showed the cytokine is primarily produced by CD45- tumor cells. These results suggest a model where ongoing IL-8 production by GBM cells maintains an immunosuppressive microenvironment by signaling to myeloid macrophages within the tumor. Immunotherapies relying on T cells should now investigate whether IL-8 blockade prevents instruction of macrophages into tumor-protective suppressor cells.

  • Open Access

    Velociraptor Machine Learning Quantifies Similarity to Known Cell Types and Matches Cells Across Flow and Imaging Cytometry Platforms

    by Claire E. Cross, Asa A. Brockman, Rebecca A. Ihrie, Jonathan M. Irish

    Suspension flow cytometry enables high‐throughput cellular profiling at the single cell level, but these data lack positional information. Conversely, tissue‐based imaging cytometry techniques reveal a cell's location within the tissue architecture and can provide insight into cell biology. It would be especially valuable if data analysis tools could incorporate data from imaging and flow cytometry platforms to gain complementary strengths when quantifying features of cells and populations. We hypothesized that per‐cell Marker Enrichment Modeling (MEM) might provide a way to register cells between flow and imaging cytometry analysis. Here, we developed the Velociraptor machine learning workflow for cross‐platform cytometry analysis. Velociraptor begins with a graph‐based implementation of MEM to calculate per‐cell quantitative phenotype labels. With this information, Velociraptor can then quickly calculate similarity between each cell's phenotype and search terms describing established cell types, cells of interest, or cells observed in other samples. Velociraptor was effective in registering cells within and between cytometry platforms. Integrated identification of cell populations was tested in several challenges, including comparisons of high dimensional datasets from cancer and immunology. Tested instrument types included imaging mass cytometry (IMC), cyclic immunohistochemistry (cycIHC), suspension mass cytometry (CyTOF), and suspension spectral flow cytometry (SFC). Between IMC and CyTOF, a comparison across imaging and flow cytometry platforms that use the same mass tag probes, Velociraptor accurately identified and registered immune cell types (median F1‐measure of 0.81). Between SFC and CyTOF, a comparison of two fundamentally different probe types—fluorophores and metal tags—in suspension flow cytometry, Velociraptor was even more accurate at identifying and registering cells (concordance correlation coefficient of 0.99). Velociraptor was especially useful in heterogeneous samples where individual cells diverged in phenotype from the bulk population. In IMC imaging of human breast cancer, a previously unappreciated tumor cell subset was revealed by Velociraptor, characterized as CD15 + , and validated as spatially segregated to the tumor core. In both cycIHC (8‐dimensional imaging) and IMC imaging (40‐dimensional imaging), Velociraptor accurately identified macrophages using a single search label as input. Notably, Velociraptor worked effectively with both extremely rare and highly abundant cell types and with cell search labels calculated from data and theoretical labels based on literature and expertise. The Velociraptor algorithm is freely available at https://github.com/cytolab .

  • Open Access

    Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis

    by Nattaporn Wanachottrakul, Decha Pinkaew, Sandipan Mukherjee, Preedakorn Chunhacha, Mari Nakashima, Asa A. Brockman, Uttariya Pal, Hasseri B. Halim, Yuhong Wei, Lena Tanaka, et al.

    In the atherosclerotic intima, macrophages (MΦ) perpetuate chronic inflammation and cholesterol accumulation. Fortilin, a 172-amino-acid multifunctional protein, is abundant in the atherosclerotic intima and promotes atherogenesis, but its mechanism has remained unclear. Herein, we report that fortilin in MФ (fortilinMΦ) facilitates atherosclerosis by (a) enhancing MΦ survival, proliferation, and lipid uptake, leading to the accumulation of lipid-laden MФ in the intima and (b) inhibiting both the reverse transdifferentiation of MΦ into vascular smooth muscle cells (VSMCs) and the differentiation of mesenchymal stem cells (MSCs) into VSMCs. Mice lacking fortilinMΦ under genetically induced hypercholesterolemia (fortilinKO-MΦ-HC) exhibit drastically less atherosclerosis in their aortae compared to wild-type (fortilinWT-MΦ-HC) controls. Imaging mass cytometry reveals that the intima of fortilinKO-MΦ-HC mice contains fewer MФ but more VSMCs than that of fortilinWT-MФ-HC mice. Cell-based assays reveal that fortilin deficiency in MΦ augments low-density lipoprotein (LDL)-induced apoptosis, suppresses proliferation and foam cell formation, and boosts TGF-β1 production. Fortilin-deficient THP1 MΦ transdifferentiate into VSMCs, and their conditioned medium causes MSCs to differentiate toward VSMCs in a TGF-β1-dependent fashion. Together, these findings suggest that fortilinMΦ plays a complex facilitative role in atherogenesis and represents a viable molecular target for the treatment of atherosclerosis.


  • Open Access

    Spatial profiling of longitudinal glioblastoma reveals consistent changes in cellular architecture, post-treatment

    by Shoaib Ajaib, Steven Pollock, Gemma Hemmings, Arief Gusnanto, Aruna Chakrabarty, Azzam Ismail, Erica Wilson, Bethany Hunter, Andrew Filby, David McDonald, et al.

    Glioblastoma (GBM), the most aggressive adult brain cancer, comprises a complex tumour microenvironment (TME) with diverse cellular interactions driving progression and pathobiology. How these spatial patterns and interactions evolve with treatment remains unclear. Here, we apply imaging mass cytometry to analyse protein-level changes in paired pre- and post-treatment GBM samples from five patients. We find a significant post-treatment increase in normal brain cells alongside a reduction in vascular cells. Moreover, despite minimal overall change in cellular diversity, interactions among astrocytes, oligodendrocytes, and vascular cells increase post-treatment, suggesting reorganisation of the TME. The GBM TME cells form spatially organized layers driven by hypoxia pre-treatment, but this influence diminishes post-treatment, giving way to less organised layers with organisation driven by reactive astrocytes and lymphocytes. These findings provide insight into treatment-induced shifts in GBM’s cellular landscape, highlighting aspects of the evolving TME that appear to facilitate recurrence and are, therefore, potential therapeutic targets. Key points Spatial organisation in primary GBM consist of layers driven by the presence of hypoxia The layers in recurrent GBM appear are driven more by the presence of reactive astrocytes Increased cellular cross-talk in recurrent GBM presents novel therapeutic targets

  • Open Access

    Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex

    by Jerome S. Arceneaux, Asa A. Brockman, Rohit Khurana, Mary‐Bronwen L. Chalkley, Laura C. Geben, Aleksandar Krbanjevic, Matthew Vestal, Muhammad Zafar, Sarah Weatherspoon, Bret C. Mobley, et al.

    The advent of high‐dimensional imaging offers new opportunities to molecularly characterize diagnostic cells in disorders that have previously relied on histopathological definitions. One example case is found in tuberous sclerosis complex (TSC), a developmental disorder characterized by systemic growth of benign tumors. Within resected brain tissues from patients with TSC, detection of abnormally enlarged balloon cells (BCs) is pathognomonic for this disorder. Though BCs can be identified by an expert neuropathologist, little is known about the specificity and broad applicability of protein markers for these cells, complicating classification of proposed BCs identified in experimental models of this disorder. Here, we report the development of a customized machine learning pipeline (BAlloon IDENtifier; BAIDEN) that was trained to prospectively identify BCs in tissue sections using a histological stain compatible with high‐dimensional cytometry. This approach was coupled to a custom 36‐antibody panel and imaging mass cytometry (IMC) to explore the expression of multiple previously proposed BC marker proteins and develop a descriptor of BC features conserved across multiple tissue samples from patients with TSC. Here, we present a modular workflow encompassing BAIDEN, a custom antibody panel, a control sample microarray, and analysis pipelines—both open‐source and in‐house—and apply this workflow to understand the abundance, structure, and signaling activity of BCs as an example case of how high‐dimensional imaging can be applied within human tissues.


  • Open Access

    IL-8 Instructs Macrophage Identity in Lateral Ventricle Contacting Glioblastoma

    by Stephanie Medina, Asa A. Brockman, Claire E. Cross, Madeline J. Hayes, Bret C. Mobley, Akshitkumar M. Mistry, Silky Chotai, Kyle D. Weaver, Reid C Thompson, Lola B. Chambless, et al.

    Adult IDH-wildtype glioblastoma (GBM) is a highly aggressive brain tumor with no established immunotherapy or targeted therapy. Recently, CD32 + HLA-DR hi macrophages were discovered to have displaced resident microglia in GBM tumors that contact the lateral ventricle stem cell niche. Since these lateral ventricle contacting GBM tumors have especially poor outcomes, identifying the origin and role of these CD32 + macrophages is likely critical to developing successful GBM immunotherapies. Here, we identify these CD32 + cells as M_IL-8 macrophages and establish that IL-8 is sufficient and necessary for tumor cells to instruct healthy macrophages into CD32 + M_IL-8 M2 macrophages. Using a set of 73 GBM tumors, IL-8 protein is shown to be present in GBM tumor cells in vivo and especially common in tumors contacting the lateral ventricle. Finally, in ex vivo experiments with conditioned medium from primary human tumor cells, inhibitory antibodies to IL-8 blocked the generation of CD32 + M_IL-8 cells. These results provide a mechanistic origin for CD32 + macrophages that predominate in the microenvironment of the most aggressive GBM tumors. IL-8 and CD32 + macrophages should now be explored as targets in combination with GBM immunotherapies, especially for patients whose tumors present with radiographic contact with the ventricular subventricular zone stem cell niche.


  • Open Access

    Multiparameter Quantitative Analyses of Diagnostic Cells in Brain Tissues from Tuberous Sclerosis Complex

    by Jerome S. Arceneaux, Asa A. Brockman, Rohit Khurana, Mary-Bronwen L. Chalkley, Laura C. Geben, Matthew Vestal, Muhammad Zafar, Sarah Weatherspoon, Bret C. Mobley, Kevin C. Ess, et al.

    The advent of high-dimensional imaging approaches offers innovative opportunities to molecularly characterize diagnostic cells in disorders that have previously relied on histopathological definitions. One example of such disorders is tuberous sclerosis complex (TSC), a developmental disorder characterized by systemic growth of benign tumors. Within resected brain tissues from patients with TSC, detection of abnormally enlarged balloon cells (BCs) is pathognomonic for this disorder. Though BCs can be identified by an expert neuropathologist, little is known about the specificity and broad applicability of protein markers for these cells, complicating classification of proposed BCs identified in experimental models of this disorder. Here, we report the development of a customized machine-learning workflow ( Ba lloon Iden tifier; BAIDEN) that was trained to prospectively identify BCs in tissue sections using a histological stain compatible with high-dimensional cytometry. This approach was coupled to a custom antibody panel and 36-parameter imaging mass cytometry (IMC) to explore the expression of multiple previously proposed BC markers and develop a descriptor of BC features conserved across multiple tissue samples from patients with TSC. These findings comprise a toolbox and dataset for understanding the abundance, structure, and signaling activity of these histopathologically abnormal cells, and an example case of how such tools can be developed and applied within human tissues.

  • Open Access

    An immunosuppressed microenvironment distinguishes lateral ventricle–contacting glioblastomas

    by Todd Bartkowiak, Sierra M. Lima, Madeline J. Hayes, Akshitkumar M. Mistry, Asa A. Brockman, Justine Sinnaeve, Nalin Leelatian, Caroline E. Roe, Bret C. Mobley, Silky Chotai, et al.

    Radiographic contact of glioblastoma (GBM) tumors with the lateral ventricle and adjacent stem cell niche correlates with poor patient prognosis, but the cellular basis of this difference is unclear. Here, we reveal and functionally characterize distinct immune microenvironments that predominate in subtypes of GBM distinguished by proximity to the lateral ventricle. Mass cytometry analysis of isocitrate dehydrogenase wild-type human tumors identified elevated T cell checkpoint receptor expression and greater abundance of a specific CD32 + CD44 + HLA-DR hi macrophage population in ventricle-contacting GBM. Multiple computational analysis approaches, phospho-specific cytometry, and focal resection of GBMs validated and extended these findings. Phospho-flow quantified cytokine-induced immune cell signaling in ventricle-contacting GBM, revealing differential signaling between GBM subtypes. Subregion analysis within a given tumor supported initial findings and revealed intratumor compartmentalization of T cell memory and exhaustion phenotypes within GBM subtypes. Collectively, these results characterize immunotherapeutically targetable features of macrophages and suppressed lymphocytes in GBMs defined by MRI-detectable lateral ventricle contact.


  • Open Access

    Jedi-1/MEGF12-mediated phagocytosis controls the pro-neurogenic properties of microglia in the ventricular-subventricular zone

    by Vivianne E. Morrison, Matthew G. Houpert, Jonathan B. Trapani, Asa A. Brockman, Philip J. Kingsley, Ketaki A. Katdare, Hillary M. Layden, Gabriela Nguena-Jones, Alexandra J. Trevisan, Kathleen A. Maguire-Zeiss, et al.

    Microglia are the primary phagocytes in the central nervous system and are responsible for clearing dead cells generated during development or disease. The phagocytic process shapes the phenotype of the microglia, which affects the local environment. A unique population of microglia reside in the ventricular-subventricular zone (V-SVZ) of neonatal mice, but how they influence this neurogenic niche is not well-understood. Here, we demonstrate that phagocytosis creates a pro-neurogenic microglial phenotype in the V-SVZ and that these microglia phagocytose apoptotic cells via the engulfment receptor Jedi-1. Deletion of Jedi-1 decreases apoptotic cell clearance, triggering the development of a neuroinflammatory phenotype, reminiscent of neurodegenerative and-age-associated microglia, that reduces neural precursor proliferation via elevated interleukin (IL)-1β signaling; inhibition of IL-1 receptor rescues precursor proliferation in vivo. Together, these results reveal a critical role for Jedi-1 in connecting microglial phagocytic activity to a phenotype that promotes neurogenesis in the developing V-SVZ. Graphical Jedi-1-dependent phagocytosis supports neurogenesis via suppression of microglial inflammatory pathway activation: Top: Wild-type Proliferative-zone-Associated Microglia (PAMs) (cyan) use the engulfment receptor Jedi-1 (‘Jedi’) to engulf apoptotic cells (yellow) in the neurogenic ventricular-subventricular zone (V-SVZ) of the early postnatal brain. Jedi activation supports neural precursor cell (NPC) proliferation and the generation of new neurons. Bottom: Deletion of Jedi reduces microglial phagocytosis and transforms PAMs into Disease-associated Inflammatory Microglia (DIMs) characterized by the upregulation of canonical inflammatory genes and core DIM markers iden ified in the aging and neurodegenerative brain (Nlrp3, NLR family pyrin domain-containing 3; Tnf, tumor necrosis factor; Ccl4, C-C chemokine ligand 4 (also called macrophage inflammatory protein 1β); Ccr5, C-C chemokine receptor type 5). Increased interleukin-1β (IL-1β) synthesis, release, and signaling in the Jedi-null V-SVZ reduces NPC proliferation and newborn neuron number. Highlights: The engulfment receptor Jedi-1 is expressed by microglia in the neonatal ventricular-subventricular zone (V-SVZ) neurogenic niche. Jedi-1 knockout microglia have decreased engulfment ability, resulting in accumulation of dead cells in the V-SVZ. Loss of Jedi-1 leads to a neuroinflammatory phenotype in microglia that is characteristic of neurodegenerative and age-associated microglia. Microglial-specific loss of Jedi -1 reduces neurogenesis, which is rescued in vivo by inhibition of interleukin-1β signaling.


  • Open Access

    Dephosphorylation of 4EBP1/2 Induces Prenatal Neural Stem Cell Quiescence

    by Laura C. Geben, Asa A. Brockman, Mary Bronwen L. Chalkley, Serena R. Sweet, Julia E. Gallagher, Alexandra L. Scheuing, Richard B. Simerly, Kevin C. Ess, Jonathan M. Irish, Rebecca A. Ihrie

    A limiting factor in the regenerative capacity of the adult brain is the abundance and proliferative ability of neural stem cells (NSCs). Adult NSCs are derived from a subpopulation of embryonic NSCs that temporarily enter quiescence during mid-gestation and remain quiescent until postnatal reactivation. Here we present evidence that the mechanistic/mammalian target of rapamycin (mTOR) pathway regulates quiescence entry in embryonic NSCs of the developing forebrain. Throughout embryogenesis, two downstream effectors of mTOR, p-4EBP1/2 T37/46 and p-S6 S240/244, were mutually exclusive in NSCs, rarely occurring in the same cell. While 4EBP1/2 was phosphorylated in stem cells undergoing mitosis at the ventricular surface, S6 was phosphorylated in more differentiated cells migrating away from the ventricle. Phosphorylation of 4EBP1/2, but not S6, was responsive to quiescence induction in cultured embryonic NSCs. Further, inhibition of p-4EBP1/2, but not p-S6, was sufficient to induce quiescence. Collectively, this work offers new insight into the regulation of quiescence entry in embryonic NSCs and, thereby, correct patterning of the adult brain. These data suggest unique biological functions of specific posttranslational modifications and indicate that the preferential inhibition of such modifications may be a useful therapeutic approach in neurodevelopmental diseases where NSC numbers, proliferation, and differentiation are altered.